Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0034186 (pyelonephritis)
 6,144 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

15 cases of pneumonia and 15 cases of pyelonephritis were included in a clinical trial of parenteral cefoperazone. The organisms isolated from patients with bacterial pneumonia were: Staphylococcus aureus (6), Klebsiella pneumoniae (5), Diplococcus pneumoniae (3), Pseudomonas species (2), and 6 others. Amongst those with pyelonephritis, Escherichia coli (12), Enterobacter (1), and 3 other pathogens, were isolated. All were sensitive to cefoperazone. The efficacy of cefoperazone in patients with pneumonia was: good in 11 (73%), fair in 3, and poor in 1. In pyelonephritis, 12 (80%) responded well and in the other 3 response was fair. There were no significant side effects or hypersensitivity reactions.
 ...
PMID:A clinical trial with cefoperazone in pneumonia and pyelonephritis. 645 94

Morphological and microbiological techniques were used to locate and identify the microorganisms that colonized the human ileal conduits in 17 different patients from 5 days after surgery up to as many as 16 years of service as a urine conduit. The ecological sequence of this colonization assumes some practical importance because the ascending growth of pathogenic organisms in this essentially open, unvalved urinary tract diversion system leads to the development of life-threatening pyelonephritis. Extensive examination of the microvillus surfaces of the ilea of five accident victims by both transmission and scanning electron microscopy showed that these tissue surfaces were not colonized by bacteria, even in the absence of prophylactic antibiotic therapy, and that these surfaces were not occupied by adherent microorganisms after several years of service as a urine conduit, even when the skin surface stoma and the conduit contents were heavily colonized by bacteria and yeasts. During the initial period (10 days) of postoperative antibiotic therapy, the mucus and urine within the conduit were largely colonized by yeasts. A mixed population of yeasts and gram-positive cocci subsequently developed in the conduit itself, and gram-positive cocci were seen to be avidly adherent to epidermal cells at the stoma. As antibiotic protection was gradually withdrawn, gram-negative organisms became a part of the mixed microbial flora of the conduit contents, and some of the potentially pathogenic organisms of this group (e.g., Escherichia spp., Proteus spp., Pseudomonas spp., etc.) were isolated from patients with pyelonephritis that appeared to come from the ileal conduit.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Microbial colonization of human ileal conduits. 651 82

The beta-lactam antibiotic thienamycin is rather unstable and is metabolized in man by renal dehydropeptidase-I. The derivatives of the antibiotic, especially N-formimidoyl-thienamycin (MK-0787) are reported to be more resistant. The antibacterial activity of N-formimidoyl-thienamycin was tested by means of the infection- and therapy model of the acute, occlusive pyelonephritis in rats. Cefotaxime was used as control agent. Even with a low dosage a clear anti-bacterial activity was proved with the E. coli- as well as especially with the Pseudomonas pyelonephritis. In our tests N-formimidoyl-thienamycin was more potent than cefotaxime.
 ...
PMID:[N-Formimidoyl-thienamycin in Animal Studies]. 657 82

Clinical efficacy of Cefmetazole was evaluated at four university hospitals and their related hospitals in Nagoya. For the treatment of urinary tract infections with or without complications, 177 patients were administered Cefmetazole. Of these patients, 69 had chronic complicated urinary tract infection defined in the UTI manual and 20 had simple acute pyelonephritis. The other urological infections for which Cefmetazole was administered included prostatitis, epididymitis, urosepsis and wound infections. Fifty four patients were given Cefmetazole intravenously after urological operation to prevent wound and urinary tract infections. The overall clinical efficacy of Cefmetazole for UTI was 76.8%; 84.4% for group 1, 85.7% for group 3, 75% for group 4, 44.4% for group 5 and 66.6% for group 6. In acute pyelonephritis due to E. coli, Klebsiella, Serratia, S. aureus, alpha-Streptococcus and S. epidermidis all patients were cured by Cefmetazole administration. Clinical efficacy of Cefmetazole was assessed to be excellent in 6 cases of prostatitis and 6 cases of acute epididymitis. E. Coli, Serratia and some organisms disappeared from blood after the administration of Cefmetazole but Pseudomonas persisted even after treatment. Postoperative administration of Cefmetazole was effective for eradication of bacteria from the urine in 26 out of 30 patients and in prevention of infection in 24 cases. After the administration of Cefmetazole skin eruption was observed in one patient and nausea in another. Slight elevation of GOT, GPT and total bilirubin was noted in 3 of the 177 patients after medication.
 ...
PMID:[Clinical evaluation of cefmetazole in urological infections]. 658 64

Total hip replacement was performed in either one or two stages in thirty-three hips with active sepsis. The sepsis had followed hemiarthroplasty in six hips, open reduction with internal fixation of a fracture in eight, cup arthroplasty in one, and total hip replacement in eight hips within six years prior to the second total hip replacement. Ten additional patients had total hip replacement following destruction of the hip joint by hematogenous sepsis in nine and by infection following a shrapnel wound in one. Of these thirty-three patients, twenty-three (70 per cent) reveal no signs of infection at three to nine years after prosthetic replacement. Of the remaining ten in whom an infection developed, six had definite recurrences of the original infection, three were infected with organisms different from the original one, and one was either a local recurrence or reseeding from a persistent pyelonephritis. The success rate when the original organism was gram-positive was 78 per cent, including two of three total hip replacements done in the presence of active infection with Staphylococcus epidermidis. The success with gram-negative organisms, however, was only 58 per cent. The prosthetic failure rate was highest in patients who had had a previous infection about a total hip replacement (37 per cent) and in patients who had had a previous infection but no prior prosthetic or internal fixation devices (37 per cent). The lowest prosthetic failure rates were in patients with an infected hemiarthroplasty (16 per cent), an infection around an internal fixation device (25 per cent), or an infected cup arthroplasty. A complete and differential blood-cell count, erythrocyte sedimentation rate, aspiration arthrogram, and radiographs did not effectively predict success or failure. For gram-positive infections, the success rates were similar following either a one or a two-stage procedure. We found that the success rates could be improved by a repeat course of parenteral antibiotics after the total hip replacement even if all preoperative and intraoperative studies failed to identify an infection. Patients with a successful total hip replacement achieved much better functional results than those who had to have a Girdlestone procedure. However, all patients must be carefully assessed prior to reimplantation of a prosthesis because of the high failure rate, especially with gram-negative organisms (Pseudomonas having the gravest prognosis), even when the procedure is done in two stages.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Total hip replacement in the previously septic hip. 665 39

Experimental pyelonephritis was produced in mice by the intravenous injection of Pseudomonas aeruginosa. Immune response to infection was studied by passive hemagglutination antibody titers. Vaccination of mice with live P. aeruginosa or culture filtrates (Pseudomonas antigen) induced antibodies and resulted in a high degree of protection against death and pyelonephritis following subsequent hematogenous challenge with the homologous strain. Transfer of immune serum protected mice against death following infection with the homologous strain and with a heterologous strain. However, immune serum failed to protect mice from kidney infection by the heterologous strain. These data indicate that immune serum seemed to protect against early, overwhelming bacteremia but did not prevent a chronic course of kidney infection by a heterologous strain.
 ...
PMID:Effect of active and passive immunization on the development of experimental Pseudomonas aeruginosa pyelonephritis in mice. 678 87

Elastase- and protease- producing strain of Pseudomonas aeruginosa induced ascending pyelonephritis in mice by intracystic challenge. The pelvis was the site of primary foci development and necrotic, purulent lesions spread from the pelvis to the perihilar area and to the cortex. Severe necrosis was a characteristic of the present infection and caused systemic infection and host death without the development of chronic lesions. In animals challenged with inocula great enough to destroy the cystic mucosa, immediate hematogenous systemic infection without cellular responses led to host death.
 ...
PMID:Ascending pyelonephritis with Pseudomonas aeruginosa in mice. 681 Jun 50

Eighteen patients, aged 18-84 years, with complicated urinary tract infections admitted to hospital were treated preoperatively with azlocillin (Securopen) for 5 to 10 days. Two patients having chronic pyelonephritis were not operated. Isolates bacteria were Pseudomonas aeruginosa (14), Proteus mirabilis (3), Escherichia coli (2) and Klebsiella spp. (1). Serum concentrations and urine recovery were measured on the fifth day of treatment. The mean serum half-life was 1.85 h and the mean value of the urine recovery 47% of the single dose. On the 5th day of treatment the urine was sterile in 80% of the patients. In 12 patients (60%) the urine was still sterile when controlled 2-6 months after operation and prophylactic postoperative treatment with nitrofurantoin or trimethoprim-sulfamethoxazole.
 ...
PMID:Preoperative treatment with azlocillin in complicated urinary tract infections. 694 9

The effect of intravenous injection of Pseudomonas aeruginosa in mice was studied in various conditions : dose of bacteria injected (2.5 X 10(6) to 4.5 X 10(7)) , moment of necropsy (one hour to 4 months after infection), number of injections (one, two and eight). Gross and microscopic examinations of tissues included kidney, lung, spleen and liver. The frequency, the type and the time of appearance of the lesions depend upon the dose of organisms, upon the individual susceptibility of the mouse and upon the number of injections. Abscesses preferentially localised in kidneys appeared in mice that received only one injection of bacteria. They were visible to the naked eye as soon as two days after inoculation with a large dose. Granulomatous inflammatory reaction was observed in the different tissues, however it was predominantly seen in the kidney and in animals that received several injections. In the liver and the spleen hyperplasia and hypertrophy of lymphoid, myeloid, megacaryocytic and mononuclear phagocytic cells were observed. This model of experimental pyelonephritis due to P. aeruginosa seems to us useful to study the factors promoting localisation and multiplication of this organism in a tissue.
 ...
PMID:[Histopathological observations of experimental hematogenous infection with Pseudomonas aeruginosa in mice (author's transl)]. 698 80

Ninety-four cases of pyelonephritis including 20 who had concurrent bacteremia were treated with cefamandole alone or in combination with either gentamicin or tobramycin. Doses of cefamandole ranged from 1--2 g by intermittent intravenous (VI) infusion every 4 to 8 h; gentamicin and tobramycin doses ranged from 1--1.7 mg/kg every 8 h also by intermittent IV infusion. Duration of therapy ranged from 5 to 23 days (mean 7.3 days). Both single and combination therapy successfully treated acute pyelonephritis and bacteremia in all patients. Seven strains of E. coli and one of Klebsiella pneumoniae responsible for initial infection were resistant to cephalothin but sensitive to cefamandole. Relapse with cefamandole sensitive bacteria occurred in 27% of patients receiving only cefamandole and 8% of those patients receiving combination therapy. Reinfection with cefamandole resistant organisms, predominantly Pseudomonas aeruginosa occurred in five patients. One patient had an intrarenal abscess due to E. coli which was successfully treated with 23 days of cefamandole. One patient died. However, death was due to acute pulmonary embolism, not infection. None of the patients receiving cefamandole plus gentamicin or tobramycin experienced a significant decrease in creatinine clearance during or after therapy. Skin rash, mild thrombophlebitis at the IV site and transient elevation of alkaline phosphatase and SGOT were the only side effects noted.
 ...
PMID:Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis. 701 May 44


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>